185 related articles for article (PubMed ID: 31501798)
1. Treatment with low-energy shock wave alleviates pain in an animal model of uroplakin 3A-induced autoimmune interstitial cystitis/painful bladder syndrome.
Li H; Zhang Z; Peng J; Xin Z; Li M; Yang B; Fang D; Tang Y; Guo Y
Investig Clin Urol; 2019 Sep; 60(5):359-366. PubMed ID: 31501798
[TBL] [Abstract][Full Text] [Related]
2. Chronic pelvic allodynia is mediated by CCL2 through mast cells in an experimental autoimmune cystitis model.
Bicer F; Altuntas CZ; Izgi K; Ozer A; Kavran M; Tuohy VK; Daneshgari F
Am J Physiol Renal Physiol; 2015 Jan; 308(2):F103-13. PubMed ID: 25209862
[TBL] [Abstract][Full Text] [Related]
3. Effects of low energy shock wave therapy on inflammatory moleculars, bladder pain, and bladder function in a rat cystitis model.
Wang HJ; Lee WC; Tyagi P; Huang CC; Chuang YC
Neurourol Urodyn; 2017 Aug; 36(6):1440-1447. PubMed ID: 28035695
[TBL] [Abstract][Full Text] [Related]
4. Uroplakin peptide-specific autoimmunity initiates interstitial cystitis/painful bladder syndrome in mice.
Izgi K; Altuntas CZ; Bicer F; Ozer A; Sakalar C; Li X; Tuohy VK; Daneshgari F
PLoS One; 2013; 8(8):e72067. PubMed ID: 23977210
[TBL] [Abstract][Full Text] [Related]
5. Low energy shock wave therapy attenuates mitochondrial dysfunction and improves bladder function in HCl induced cystitis in rats.
Wang HJ; Tyagi P; Lin TK; Huang CC; Lee WC; Chancellor MB; Chuang YC
Biomed J; 2022 Jun; 45(3):482-490. PubMed ID: 34224911
[TBL] [Abstract][Full Text] [Related]
6. Low-Energy Shock Wave Plus Intravesical Instillation of Botulinum Toxin A for Interstitial Cystitis/Bladder Pain Syndrome: Pathophysiology and Preliminary Result of a Novel Minimally Invasive Treatment.
Jiang YH; Jhang JF; Lee YK; Kuo HC
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203604
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a Novel Autoimmune Experimental Model of Bladder Pain Syndrome/Interstitial Cystitis in C57BL/6 Mice.
Jin XW; Liu BK; Zhang X; Zhao ZH; Shao Y
Inflammation; 2017 Jun; 40(3):861-870. PubMed ID: 28233078
[TBL] [Abstract][Full Text] [Related]
8. Autoimmunity to uroplakin II causes cystitis in mice: a novel model of interstitial cystitis.
Altuntas CZ; Daneshgari F; Sakalar C; Goksoy E; Gulen MF; Kavran M; Qin J; Li X; Tuohy VK
Eur Urol; 2012 Jan; 61(1):193-200. PubMed ID: 21719190
[TBL] [Abstract][Full Text] [Related]
9. Effects of low-intensity extracorporeal shock wave therapy on lipopolysaccharide cystitis in a rat model of interstitial cystitis/bladder pain syndrome.
Kusakabe N; Kamijo TC; Wada N; Chiba H; Shinohara N; Miyazato M
Int Urol Nephrol; 2024 Jan; 56(1):77-86. PubMed ID: 37668867
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of two different adjuvants with immunogenic uroplakin 3A-derived peptide for their ability to evoke an immune response in mice.
Izgi K; Iskender B; Sakalar C; Arslanhan A; Saraymen B; Canatan H
Eur Cytokine Netw; 2015; 26(2):46-56. PubMed ID: 26553588
[TBL] [Abstract][Full Text] [Related]
11. Effect of low-energy shock wave therapy on intravesical epirubicin delivery in a rat model of bladder cancer.
Elkashef A; Barakat N; Khater SM; Awadalla A; Belal F; El-Assmy AM; Sheir KZ; Shokeir AA
BJU Int; 2021 Jan; 127(1):80-89. PubMed ID: 32654305
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Neurokinin-1 Receptor Antagonist in an Experimental Autoimmune Cystitis Model Resembling Bladder Pain Syndrome/Interstitial Cystitis.
Liu BK; Jin XW; Lu HZ; Zhang X; Zhao ZH; Shao Y
Inflammation; 2019 Feb; 42(1):246-254. PubMed ID: 30196377
[TBL] [Abstract][Full Text] [Related]
13. Pain reduction realized with extracorporeal shock wave therapy for the treatment of symptoms associated with interstitial cystitis/bladder pain syndrome-A prospective, multicenter, randomized, double-blind, placebo-controlled study.
Chuang YC; Meng E; Chancellor M; Kuo HC
Neurourol Urodyn; 2020 Jun; 39(5):1505-1514. PubMed ID: 32394478
[TBL] [Abstract][Full Text] [Related]
14. Bladder wall injection of mesenchymal stem cells ameliorates bladder inflammation, overactivity, and nociception in a chemically induced interstitial cystitis-like rat model.
Furuta A; Yamamoto T; Igarashi T; Suzuki Y; Egawa S; Yoshimura N
Int Urogynecol J; 2018 Nov; 29(11):1615-1622. PubMed ID: 29508044
[TBL] [Abstract][Full Text] [Related]
15. Improves symptoms and urinary biomarkers in refractory interstitial cystitis/bladder pain syndrome patients randomized to extracorporeal shock wave therapy versus placebo.
Shen YC; Tyagi P; Lee WC; Chancellor M; Chuang YC
Sci Rep; 2021 Apr; 11(1):7558. PubMed ID: 33824389
[TBL] [Abstract][Full Text] [Related]
16. Cystitis-induced bladder pain is Toll-like receptor 4 dependent in a transgenic autoimmune cystitis murine model: a MAPP Research Network animal study.
Cui X; Jing X; Lutgendorf SK; Bradley CS; Schrepf A; Erickson BA; Magnotta VA; Ness TJ; Kreder KJ; O'Donnell MA; Luo Y
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F90-F98. PubMed ID: 31091120
[TBL] [Abstract][Full Text] [Related]
17. Low Energy Shock Wave Therapy Inhibits Inflammatory Molecules and Suppresses Prostatic Pain and Hypersensitivity in a Capsaicin Induced Prostatitis Model in Rats.
Wang HJ; Tyagi P; Chen YM; Chancellor MB; Chuang YC
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561455
[TBL] [Abstract][Full Text] [Related]
18. Increased mRNA expression of genes involved in pronociceptive inflammatory reactions in bladder tissue of interstitial cystitis.
Homma Y; Nomiya A; Tagaya M; Oyama T; Takagaki K; Nishimatsu H; Igawa Y
J Urol; 2013 Nov; 190(5):1925-31. PubMed ID: 23727186
[TBL] [Abstract][Full Text] [Related]
19. Urodynamic and molecular characteristics of detrusor underactivity in a rat cryoinjury model and effects of low energy shock wave therapy.
Chuang YC; Tyagi P; Wang HJ; Huang CC; Lin CC; Chancellor MB
Neurourol Urodyn; 2018 Feb; 37(2):708-715. PubMed ID: 28767169
[TBL] [Abstract][Full Text] [Related]
20. A MAPP Network study: overexpression of tumor necrosis factor-α in mouse urothelium mimics interstitial cystitis.
Yang W; Searl TJ; Yaggie R; Schaeffer AJ; Klumpp DJ
Am J Physiol Renal Physiol; 2018 Jul; 315(1):F36-F44. PubMed ID: 29465304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
